Maternal prenatal and/or postnatal n-3 long chain polyunsaturated fatty acids (LCPUFA) supplementation for preventing allergies in early childhood

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 7, 2015, Pages

  Gunaratne, Anoja W ^a,b   Makrides, Maria ^a,b,c   Collins, Carmel T ^a,b,c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^c SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; LONG CHAIN FATTY ACID; OMEGA 3 FATTY ACID; PLACEBO; POLLEN ANTIGEN;

ALLERGIC RHINITIS; ALLERGY; ASTHMA; ATOPIC DERMATITIS; CAT; DIET SUPPLEMENTATION; ECZEMA; EGG; FEMALE; FISH; FOOD ALLERGY; HIGH RISK POPULATION; HUMAN; MATERNAL NUTRITION; META ANALYSIS; MILK; OUTCOME ASSESSMENT; PEANUT; PERINATAL PERIOD; POLLEN ALLERGY; PRENATAL PERIOD; PRICK TEST; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; WHEAT; WHEEZING; AGE; FOOD HYPERSENSITIVITY; HYPERSENSITIVITY; IMMUNOLOGY; INFANT; NEWBORN; POSTNATAL CARE; PREGNANCY; PRENATAL CARE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL (TOPIC);

AGE FACTORS; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; FOOD HYPERSENSITIVITY; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; INFANT; INFANT, NEWBORN; POSTNATAL CARE; PREGNANCY; PRENATAL CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84957410116     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010085.pub2     Document Type: Review

References (203)

1. Barden AE, Dunstan JA, Beilin LJ, Prescott SL, Mori TA. n - 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids. Clinical Science 2006;111(4):289-94.
2. Barden AE, Mori TA, Dunstan JA, Taylor AL, Thornton CA, Croft KD, et al. Fish oil supplementation in pregnancy lowers f2-isoprostanes in neonates at high risk of atopy. Free Radical Research 2004;38(3):233-9.
3. Denburg JA, Hatfield HM, Cyr MM, Hayes L, Holt PG, Sehmi R, et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research 2005;57(2):276-81.
4. Dunstan JA, Mitoulas LR, Dixon G, Doherty DA, Hartmann PE, Simmer K, et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatric Research 2007;62(6):689-94.
5. Dunstan JA, Mori TA, Barden A, Beilin LJ, Holt PG, Calder PC, et al. Effects of n-3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. European Journal of Clinical Nutrition 2004;58:429-37.
6. Dunstan JA, Mori TA, Barden A, Beilin LJ, Taylor AL, Holt PG, et al. Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. Journal of Allergy and Clinical Allergy Immunology 2003;112(6):1178-84.
7. Dunstan JA, Mori TA, Barden A, Beilin LJ, Taylor AL, Holt PG, et al. Maternal fish oil supplementation in pregnancy reduces interleukin-13 levels in cord blood of infants at high risk of atopy. Clinical and Experimental Allergy 2003;33(4):442-8.
8. Dunstan JA, Roper J, Mitoulas L, Hartmann PE, Simmer K, Prescott SL. The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clinical and Experimental Allergy 2004;34(8):1237-42.
9. Dunstan JA, Simmer K, Dixon G, Prescott SL. Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood Fetal and Neonatal Edition 2008;93(1):F45-F50.
10. Hatfield HM, Dunstan JA, Hayes L, Sehmi R, Holt PM, Denberg JA, et al. Dietary N-3 polyunsaturated fatty acid (PUFA) supplementation during pregnancy is associated with changes in cord blood (CB) progenitor numbers and responsiveness to IL-5 in infants at risk of atopy [abstract]. Journal of Allergy and Clinical Immunology 2003;111(2 Suppl).):S320.
11. Mattes E, McCarthy S, Gong G, van Eekelen JA, Dunstan J, Foster J, et al. Maternal mood scores in mid-pregnancy are related to aspects of neonatal immune function. Brain, Behavior, and Immunity 2009;23(3):380-8.
12. Prescott SL, Barden AE, Mori TA, Dunstan JA. Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord-blood-derived neutrophils. Clinical Science 2007;113(10):409-16.
13. Furuhjelm C, Jenmalm MC, Falth-Magnusson K, DuchIn K. Th1 and Th2 chemokines, vaccine-induced immunity, and allergic disease in infants after maternal ω-3 fatty acid supplementation during pregnancy and lactation. Pediatric Research 2011;69(3):259-64.
14. Furuhjelm C, Warstedt K, Fageras M, Falth-Magnusson K, Larsson J, Fredriksson M, et al. A randomised placebo controlled study of maternal n-3 fatty acid supplementation during pregnancy and lactation. Allergy 2008;63(Suppl 88):53.
15. Furuhjelm C, Warstedt K, Fageras M, Falth-Magnusson K, Larsson J, Fredriksson M, et al. A randomised placebo controlled study of omega-3-fatty acid supplementation during pregnancy and lactation. Skin sensitisation in the children. Allergy 2007;62(Suppl 83):46.
16. Furuhjelm C, Warstedt K, Fageras M, Falth-Magnusson K, Larsson J, Fredriksson M, et al. Allergic disease in infants up to 2 years of age in relation to plasma omega-3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology 2011;22(5):505-14.
17. Furuhjelm C, Warstedt K, Larsson J, Fredriksson M, Bottcher MF, Falth-Magnusson K, et al. Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica 2009;98(9):1461-7.
18. Warstedt K, Furuhjelm C, Duchen K, Falth-Magnusson K, Fageras M. The effects of omega-3 fatty acid supplementation in pregnancy on maternal eicosanoid, cytokine, and chemokine secretion. Pediatric Research 2009;66(2):212-7.
19. Asserhoj M, Nehammer S, Matthiessen J, Michaelsen KF, Lauritzen L. Maternal fish oil supplementation during lactation may adversely affect long-term blood pressure, energy intake, and physical activity of 7-year-old boys. Journal of Nutrition 2009;139(2):298-304.
20. Cheatham CL, Nerhammer AS, Asserhoj M, Michaelsen KF, Lauritzen L. Fish oil supplementation during lactation: effects on cognition and behavior at 7 years of age. Lipids 2011;46(7):637-45.
21. Jorgensen MH, Michaelsen KF, Lauritzen L. Long chain polyunsaturated fatty acids and liver biochemistry in breast-fed infants. Journal of Pediatric Gastroenterology and Nutrition 2005;40(5):631-2.
22. Larnkjaer A, Christensen JH, Michaelsen KF, Lauritzen L. Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5-y-old children. Journal of Nutrition 2006;136(6):1539-44.
23. Lauritzen L, Hoppe C, Straarup EM, Michaelsen KF. Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatric Research 2005;58(2):235-42.
24. Lauritzen L, Jorgensen MH, Mikkelsen TB, Skovgaard M, Straarup EM, Olsen SF, et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n-3 fatty acid content of infant erythrocytes. Lipids 2004;34(3):195-206.
25. Lauritzen L, Jorgensen MH, Olsen SF, Straarup EM, Michaelsen KF. Maternal fish oil supplementation in lactation: effect on developmental outcome in breast-fed infants. Reproduction, Nutrition, Development 2005;45(5):535-47.
26. Lauritzen L, Kjaer TM, Fruekilde MB, Michaelsen KF, Frokiaer H. Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2-year-old children. Lipids 2005;40(7):669-76.
27. Ulbak J, Lauritzen L, Hansen HS, Michaelsen KF. Diet and blood pressure in 2.5-y-old Danish children. American Journal of Clinical Nutrition 2004;79(6):1095-102.
28. Atwell K, Collins CT, Sullivan TR, Ryan P, Gibson RA, Makrides M, et al. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatric Child Health 2013;49(1):E17-E22.
29. Collins CT, Gibson RA, Miller J, McPhee AJ, Willson K, Smithers LG, et al. Carbohydrate intake is the main determinant of growth in infants born <33 weeks' gestation when protein intake is adequate. Nutrition 2008;24:451-7.
30. Collins CT, Makrides M, Gibson RA, McPhee AJ, Davis PG, Doyle LW, et al. Pre and post-term growth in pre-term infants supplemented with higher-dose DHA: a randomised controlled trial. British Journal of Nutrition 2011;105(11):1635-43.
31. Gunaratne AW. Effects of n-3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis-submitted]. University of Adelaide, 2014 July.
32. Hawkes JS, Bryan DL, Makrides M, Neumann MA, Gibson RA. A randomized trial of supplementation with docosahexaenoic acid-rich tuna oil and its effects on the human milk cytokines interleukin 1beta, interleukin 6, and tumor necrosis factor a. American Journal of Clinical Nutrition 2002;75(4):754-60.
33. Makrides M, Gibson RA, McPhee AJ, Collins CT, Davis PG, Doyle LW, et al. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomised controlled trial. JAMA 2009;301(2):175-82.
34. Manley BJ, Makrides M, Collins CT, McPhee AJ, Gibson RA, Ryan P, et al. High-dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics 2011;128(1):e71-e77.
35. Simmonds L. Behavioural and Allergic Disease Assessment at Pre-School Age: A Follow-up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov.
36. Smithers LG, Collins CT, Simmonds LA, Gibson RA, McPhee A, Makrides M. Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow-up study of a randomised controlled trial. American Journal of Clinical Nutrition 2010;91(3):628-34.
37. Smithers LG, Gibson RA, Makrides M. Long-chain polyunsaturated fatty acid supplementation for infants born preterm. NeoReviews 2007;8:143-51.
38. Smithers LG, Gibson RA, McPhee A, Makrides M. Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukotrins and Essential Fatty Acids 2008;79(3-5):141-6.
39. Smithers LG, Gibson RA, McPhee A, Makrides M. Higher dose of docosahexaenoic acid in the neonatal period improved visual acuity of preterm infants: results of a randomised controlled trial. American Journal of Clinical Nutrition 2008;88(4):1049-56.
40. Smithers LG, Makrides M, Gibson RA. Human milk fatty acids from lactating mothers of preterm infants: A study revealing wide intra- and inter-individual variation. Prostaglandins, Leukotrienes and Essential Fatty Acids 2010;83(1):9-13.
41. Gunaratne AW. Effects of n-3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis-submitted]. University of Adelaide, 2014 July.
42. Makrides M. A randomised trial of DHA in pregnancy to prevent postnatal depression symptoms and enhance neurodevelopment in children: the DOMINO trial. Australian Clinical Trials Register (http://www.actr.org/actr) [accessed 6 December 2005] 2005.
43. Makrides M, Gibson RA, McPhee AJ, Yelland L, Quinlivan J. Effect of docosahexaenoic acid (DHA) supplementation during pregnancy on neurodevelopment of young children: The domino trial. Journal of Paediatrics and Child Health 2011;47(Suppl 1):89.
44. Makrides M, Gibson RA, McPhee AJ, Yelland L, Quinlivan J, Ryan P, et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA 2010;304(15):1675-83.
45. Makrides M, Gould JF, Gawlik NR, Yelland LN, Smithers LG, Anderson PJ, et al. Four-year follow-up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA 2014;311(17):1802-4.
46. Palmer DJ, Sullivan T, Gold MS, Prescott SL, Heddle R, Gibson RA, et al. Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ 2012;344(e184):1-11.
47. Palmer DJ, Sullivan T, Gold MS, Prescott SL, Heddle R, Gibson RA, et al. Effect of n-3 polyunsaturated fatty acid supplementation in pregnancy on early childhood allergic disease: Randomized controlled trial. Journal of Paediatrics and Child Health 2013;49 Suppl(2):56.
48. Palmer DJ, Sullivan T, Gold MS, Prescott SL, Heddle R, Gibson RA, et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy 2013;68(11):1370-6.
49. Ryan P, Griffith E, McDermott B, Makrides M, Gibson R, for the DOMINO Steering Group. Data management tools in the DOMINO trial: DHA in pregnancy to prevent postnatal depressive symptoms and enhance neurodevelopment in children. Clinical Trials 2007;4(4):426.
50. Smithers LG, Gibson RA, Makrides M. Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. American Journal of Clinical Nutrition 2011;93(6):1293-9.
51. Zhou SJ, Yelland L, McPhee AJ, Quinlivan J, Gibson RA, Makrides M. Fish-oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition 2012;95(6):1378-84.
52. Garcia-Rodriguez C, Helmersson-Karlqvis J, Mesa M, Miles E, Noakes P, Vlachava M, et al. Increased intake of salmon decreases F2-isoprostanes in pregnant women. Annals of Nutrition and Metabolism 2011;58(Suppl 3):122-3.
53. Garcia-Rodriguez C, Mesa M, Olza J, Vlachava M, Kremmyda L, Diaper N, et al. Farmed salmon supplementation enhances the enzymatic defence system. Annals of Nutrition and Metabolism 2011;58(Suppl 3):89-90.
54. Garcia-Rodriguez CE, Helmersson-Karlqvist J, Mesa MD, Miles EA, Noakes PS, Vlachava M, et al. Does increased intake of salmon increase markers of oxidative stress in pregnant women? The salmon in pregnancy study. Antioxidants and Redox Signaling 2011;15(11):2819-23.
55. Garcia-Rodriguez CE, Mesa MD, Olza J, Vlachava M, Kremmyda LS, Diaper ND, et al. Does consumption of two portions of salmon per week enhance the antioxidant defence system in pregnant women?. Antioxidants and Redox Signaling 2012;16(12):1401-6.
56. Garcia-Rodriguez CE, Olza J, Aguilera CM, Mesa MD, Miles EA, Noakes PS, et al. Plasma inflammatory and vascular homeostasis bio markers increase during human pregnancy but are not affected by oily fish intake. Journal of Nutrition 2012;142(7):1191-6.
57. Helmersson-Karlqvist J, Miles EA, Vlachava M, Kremmyda LS, Noakes PS, Diaper ND, et al. Enhanced prostaglandin F2alpha formation in human pregnancy and the effect of increased oily fish intake: results from the Salmon in Pregnancy Study. Prostaglandins Leukotrienes and Essential Fatty Acids 2012;86(1-2):35-8.
58. Miles EA, Noakes PS, Kremmyda LS, Vlachava M, Diaper ND, Rosenlund G, et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n-3 fatty acid intake, and marine n-3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition 2011;94(6 Suppl):1986S-92S.
59. Noakes PS, Vlachava M, Kremmyda LS, Diaper ND, Miles EA, Erlewyn-Lajeunesse M, et al. Increased intake of oily fish in pregnancy: effects on neonatal immune responses and on clinical outcomes in infants at 6 mo. American Journal of Clinical Nutrition 2012;95(2):395-404.
60. Rossary A, Farges M, Lamas B, Miles EA, Noakes PS, Kremmyda L, et al. Increased consumption of salmon during pregnancy partly prevents the decline of some plasma essential amino acid concentrations in pregnant women. Clinical Nutrition 2014;33(2):267-73.
61. Rossary A, Farges MC, Vlachava M, Kremmyda LS, Diaper ND, Noakes PS, et al. Does salmon consumption by pregnant women change amino acids availability?. Clinical Nutrition Supplement 2011;6(1):109.
62. Urwin HJ, Miles EA, Noakes PS, Kremmyda L, Vlachava M, Diaper ND, et al. Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin. British Journal of Nutrition 2014;111(5):733-84.
63. Urwin HJ, Miles EA, Noakes PS, Kremmyda LS, Vlachava M, Diaper ND, et al. Salmon consumption during pregnancy alters fatty acid composition and secretory IgA concentration in human breast milk. Journal of Nutrition 2012;142(8):1603-10.
64. van den Elsen LW, Noakes PS, van der Maarel MA, Kremmyda LS, Vlachava M, Diaper ND, et al. Salmon consumption by pregnant women reduces ex vivo umbilical cord endothelial cell activation. American Journal of Clinical Nutrition 2011;94(6):1418-25.
65. Boris J, Jensen B, Salvig JD, Secher NJ, Olsen SF. A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n-3 fatty acid content in human breast milk. Lipids 2004;39(12):1191-6.
66. Olsen SF, Osterdal ML, Salvig JD, Mortensen LM, Rytter D, Secher NJ, et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry-based follow-up from a randomized controlled trial. American Journal of Clinical Nutrition 2008;88(1):167-75.
67. Olsen SF, Osterdal ML, Salvig JD, Weber T, Tabor A, Secher NJ. Duration of pregnancy in relation to fish oil supplementation and habitual fish intake: a randomised clinical trial with fish oil. European Journal of Clinical Nutrition 2007;61(8):976-85.
68. Olsen SF, Secher NJ. Fish oil and preeclampsia. 8th World Congress of the International Society for the Study of Hypertension in Pregnancy; 1992 November 8-12; Buenos Aires, Argentina. 1992:94.
69. Olsen SF, Secher NJ, Sorensen JD, Grant A. Gestational age and fish oil supplementation in third trimester: a population-based randomized controlled trial. International Journal of Gynecology and Obstetrics 1991;36 Suppl:31.
70. Olsen SF, Sorensen JD, Secher NJ, Hedegaard M, Henriksen TB, Hansen HS, et al. Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration. Lancet 1992;339:1003-7.
71. Olsen SF, Søorensen JD, Secher NJ, Hedegaard M, Henriksen TB, Hansen HS, et al. Fish oil supplementation and duration of pregnancy. A randomized controlled trial [Fiskeolietilskud og graviditetsvarighed. En randomiseret kontrolleret undersogelse.]. Ugeskrift for Laeger 1994;156(9):1302-7.
72. Rytter D, Bech BH, Christensen JH, Schmidt EB, Henriksen TB, Olsen SF. Intake of fish oil during pregnancy and adiposity in 19-y-old offspring: Follow-up on a randomized controlled trial. American Journal of Clinical Nutrition 2011;94(3):701-8.
73. Rytter D, Christensen JH, Bech BH, Schmidt EB, Henriksen TB, Olsen SF. The effect of maternal fish oil supplementation during the last trimester of pregnancy on blood pressure, heart rate and heart rate variability in the 19-year-old offspring. British Journal of Nutrition 2012;108(8):1475-83.
74. Rytter D, Schmidt EB, Bech BH, Christensen JH, Henriksen TB, Olsen SF. Fish oil supplementation during late pregnancy does not influence plasma lipids or lipoprotein levels in young adult offspring. Lipids 2011;46(12):1091-9.
75. Salvig JD, Olsen SF, Secher NJ. Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology 1996;103:529-33.
76. Sorensen JD, Olsen SF, Pedersen AK, Boris J, Secher NJ, FitzGerald GA. Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. American Journal of Obstetrics and Gynecology 1993;168:915-22.
77. Sorensen JD, Olsen SF, Pedersen AK, Boris J, Secher NJ, FitzGerald GA. Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. International Journal of Gynecology and Obstetrics 1993;43:229.
78. Sorensen JD, Olsen SF, Secher NJ. Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled study. Acta Obstetricia et Gynecologica Scandinavica Supplement 1995;73:110.
79. Sorensen JD, Olsen SF, Secher NJ, Jespersen J. Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis A randomised controlled study. Fibrinolysis 1994;8:54-60.
80. Van Houwelingen AC, Sorensen JD, Hornstra G, Simonis MMG, Boris J, Olsen SF, et al. Essential fatty acid status in neonates after fish-oil supplementation during late pregnancy. British Journal of Nutrition 1995;74:723-31.
81. Escamilla-Nunez MC, Barraza-Villarreal A, Hernandez-Cadena L, Navarro-Olivos E, Sly PD, Romieu I. Omega-3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest 2014; Vol. 146, issue 2:373-82.
82. Hernandez E, Barraza-Villarreal A, Escamilla-Nunez MC, Hernandez-Cadena L, Sly PD, Neufeld LM, et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy & Asthma Proceedings 2013;34(5):e27-34.
83. Imhoff-Kunsch B, Stein AD, Martorell R, Parra-Cabrera S, Romieu I, Ramakrishnan U. Prenatal docosahexaenoic acid supplementation and infant morbidity: Randomized controlled trial. Pediatrics 2011;128(3):e505-12.
84. Imhoff-Kunsch B, Stein AD, Villalpando S, Martorell R, Ramakrishnan U. Docosahexaenoic acid supplementation from mid-pregnancy to parturition influenced breast milk fatty acid concentrations at 1 month postpartum in Mexican women. Journal of Nutrition 2011;141(2):321-6.
85. Lee HS, Barraza-Villarreal A, Hernandez-Vargas H, Sly PD, Biessy C, Ramakrishnan U, et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with omega-3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition 2013;98(2):480-7.
86. Ramakrishnan U, Di A, Schnaas L, Stein AD, Wang M, Martorell R, et al. Effect of prenatal supplementation with docosahexanoic acid on infant development: A randomized placebo-controlled trial in Mexico. FASEB Journal 2010;24(Suppl):Abstract no 227.6.
87. Ramakrishnan U, Stein AD, Parra-Cabrera S, Wang M, Imhoff-Kunsch B, Juirez-Mirquez S, et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double-blind, placebo-controlled trial in Mexico. Food and Nutrition Bulletin 2010;31(2 Suppl):S108-16.
88. Romieu I, Barraza-Villarreal A, Hernandez-Cadena L, Escamilla-Nunez C, Sly P, Neulfeld L, et al. Supplementation with omega-3 fatty acids and atopy symptoms in infants: A randomized controlled trial. American Journal of Epidemiology 2008;167(11):S23.
89. Romieu I, Barraza-Villarreal A, Hernandez-Cadena L, Escamilla-Nunez C, Sly P, Neulfeld L, et al. Supplementation with omega-3 fatty acids and atopy symptoms in infants: a randomized controlled trial. European Respiratory Society Annual Congress; 2008 October 4-8; Berlin, Germany. 2008:346s.
90. Romieu I, Hernandez E, Barraza-Villarreal A, Escamilla-Nunez C, Sly P, Neufeld L, et al. Predictors of cord blood ige levels in child: preliminary results of a randomized controlled trial of Omega-3 PUFA supplementation during pregnancy [Abstract]. Journal of Allergy and Clinical Immunology 2009;123(2 Suppl 1):S193.
91. Romieu I, Lee H, Barraza A, Biessy C, Duarte-Salles T, Sly P, et al. Dietary supplementation with polyunsaturated fatty acid during pregnancy modulates DNA methylation at IGF2/H19 imprinted genes and growth of infants. FASEB Journal 2014;28(1 Suppl 1):1120.3.
92. Stein AD, Wang M, Martorell R, Neufeld L, Flores-Ayala R, Rivera J, et al. Postnatal growth following maternal gestational supplementation with docosahexanoic acid (DHA): Randomized placebo-controlled trial in Mexico. FASEB Journal 2010;24(Suppl):Abstract no 277.5.
93. Stein AD, Wang M, Martorell R, Neufeld LM, Flores-Ayala R, Rivera JA, et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. Journal of Nutrition 2011;141(2):316-20.
94. Stein AD, Wang M, Rivera JA, Martorell R, Ramakrishnan U. Auditory-and visual-evoked potentials in Mexican infants are not affected by maternal supplementation with 400 mg/d docosahexaenoic acid in the second half of pregnancy. Journal of Nutrition 2012;142(8):1577-81.
95. Bergmann RL, Bergmann KE, Richter R, Haschke-Becher E, Henrich W, Dudenhausen JW. Does docosahexaenoic acid (DHA) status in pregnancy have any impact on postnatal growth? Six-year follow-up of a prospective randomized double-blind monocenter study on low-dose DHA supplements. Journal of Perinatal Medicine 2012;40:677-84.
96. Bergmann RL, Haschke-Becher E, Klassen-Wigger P, Bergmann KE, Richter R, Dudenhausen JW, et al. Supplementation with 200 mg/day docosahexaenoic acid from mid-pregnancy through lactation improves the docosahexaenoic acid status of mothers with a habitually low fish intake and of their infants. Annals of Nutrition and Metabolism 2008;52(2):157-66.
97. Bergmann RL, Haschke-Becher, Bergmann KE, Dudenhausen JW, Haschke F. Low dose docosahexaenoic acid supplementation improves the DHA status of pregnant women [abstract]. Pediatric Academic Societies Annual Meeting; 2006 April 29-May 2; San Francisco, CA, USA. 2006.
98. Bergmann RL, Richter R, Bergmann KE, Dudenhausen JW, Haschke F. 21 months old infants are leaner if their mothers received low dose DHA supplements during pregnancy and lactation. European Journal of Pediatrics 2006;165 Suppl 1:114.
99. Campos-Martinez A, Serrano- L, Medina- M, Ochoa- J, Pena-Caballero M. Levels of docosahexaenoic acid in pregnant women and their children after taking a fish oil enriched diet. Journal of Maternal-Fetal and Neonatal Medicine 2012;25(S2):92.
100. Carlson SE. DHA supplementation and pregnancy outcome. ClinicalTrials.gov (http://clinicaltrials.gov/) [accessed 21 March 2006] 2006.
101. Carlson SE, Colombo J, Gajewski BJ, Gustafson KM, Mundy D, Yeast J, et al. DHA supplementation and pregnancy outcomes. American Journal of Clinical Nutrition 2013;97(4):808-15.
102. Colombo J, Kannass KN, Shaddy DJ, Kundurthi S, Maikranz JM, Anderson CJ, et al. Maternal DHA and the development of attention in infancy and toddlerhood. Child Development 2004;75(4):1254-67.
103. Courville AB, Harel O, Lammi-Keefe CJ. Consumption of a DHA-containing functional food during pregnancy is associated with lower infant ponderal index and cord plasma insulin concentration. British Journal of Nutrition 2011;106(2):208-12.
104. Granot E, Jakobovich E, Rabinowitz R, Levy P, Schlesinger M. DHA supplementation during pregnancy and lactation affects infants' cellular but not humoral immune response. Mediators of Inflammation 2011;2011:493925.
105. Brunner S, Schmid D, Huttinger K, Much D, Bruderl M, Sedlmeier EM, et al. Effect of a dietary intervention to reduce the n-6/n-3 fatty acid ratio on the maternal and cord blood leptin axis and relation of leptin to body composition in the offspring - Results of the infat-study (pepo-consortium of the competence network obesity). Obesity Facts 2012;5(Suppl 2):10.
106. Hauner H, Much D, Vollhardt C, Brunner S, Schmid D, Sedlmeier EM, et al. Effect of reducing the n-6:n-3 long-chain PUFA ratio during pregnancy and lactation on infant adipose tissue growth within the first year of life: An open-label randomized controlled trial. American Journal of Clinical Nutrition 2012;95(2):383-94.
107. Hauner H, Vollhardt C, Schneider KT, Zimmermann A, Schuster T, Amann-Gassner U. The impact of nutritional fatty acids during pregnancy and lactation on early human adipose tissue development. Rationale and design of the INFAT study. Annals of Nutrition and Metabolism 2009;54(2):97-103.
108. Much D, Brunner S, Vollhardt C, Schmid D, Sedlmeier EM, Bruderl M, et al. Effect of dietary intervention to reduce the n-6/n-3 fatty acid ratio on maternal and fetal fatty acid profile and its relation to offspring growth and body composition at 1 year of age. European Journal of Clinical Nutrition 2013;67(3):282-8.
109. Helland IB, Saarem K, Saugstad OD, Drevon CA. Fatty acid composition in maternal milk and plasma during supplementation with cod liver oil. European Journal of Clinical Nutrition 1998;52(11):839-45.
110. Helland IB, Saugstad OD, Saarem K, Van Houwelingen AC, Nylander G, Drevon CA. Supplementation of n-3 fatty acids during pregnancy and lactation reduces maternal plasma lipid levels and provides DHA to the infants. Journal of Maternal-Fetal and Neonatal Medicine 2006;19(7):397-406.
111. Helland IB, Saugstad OD, Smith L, Saarem K, Solvoll K, Ganes T, et al. Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics 2001;108(5):E82.
112. Helland IB, Smith L, Blomen B, Saarem K, Saugstad OD, Drevon CA. Effect of supplementing pregnant and lactating mothers with n-3 very-long-chain fatty acids on children's IQ and body mass index at 7 years of age. Pediatrics 2008;122(2):e472-9.
113. Helland IB, Smith L, Saarem K, Saugstad OD, Drevon CA. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's iq at 4 years of age. Pediatrics 2003;111(1):e39-44.
114. Innis SM. N-3 fatty acid requirements for human development. http://clinicaltrials.gov/ct2/show/NCT00620672 (accessed 9 April 2008).
115. Innis SM, Friesen RW. Essential N-3 fatty acids in pregnant women and early visual acuity maturation in term infants. American Journal of Clinical Nutrition 2008;87(3):548-57.
116. Innis SM, Friesen RW. Maternal DHA supplementation in pregnancy: a double blind randomized prospective trial of maternal N-3 fatty acid status, human milk fatty acids and infant development. Pediatric Academic Societies Annual Meeting; 2007 May 5-8; Toronto, Canada. 2007.
117. Mulder KA, Innis SM, Richardson KJ. Cognitive performance of children 5-6 years of age is associated with children's docosahexaenoic acid (DHA), but not dietary DHA or maternal DHA in pregnancy. Pediatric Academic Societies and Asian Society for Pediatric Research Joint Meeting; 2014 May 3-6; Vancouver, Canada. 2014:Abstract no: 3680.6.
118. Mulder KA, King DJ, Innis SM. Omega-3 fatty acid deficiency in infants before birth identified using a randomized trial of maternal DHA supplementation in pregnancy. Plos One 2014;9(1):e83764.
119. Judge MP, Harel O, Lammi-Keefe CJ. A docosahexaenoic acid-functional food during pregnancy benefits infant visual acuity at four but not six months of age. Lipids 2007;42(2):117-22.
120. Karlsson T, Birberg-Thornberg U, Duchen K, Gustafsson PA. LC-PUFA supplemented to mothers during pregnancy and breast-feeding improves cognitive performance in their children four years later - an rct study. 9th Congress of the ISSFAL; 29 May-2 June 2010; Maastricht, The Netherlands 2010:113.
121. Knudsen VK, Hansen HS, Osterdal ML, Mikkelsen TB, Mu H, Olsen SF. Fish oil in various doses or flax oil in pregnancy and timing of spontaneous delivery: a randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology 2006;113(5):536-43.
122. Broekaert I, Campoy C, Iznaola C, Hoffman B, Mueller-Felber W, Koletzko BV. Visual evoked potentials in infants after dietary supply of docosahexaenoic acid and 5-methyl-tetrahydrofolate during pregnancy. Journal of Pediatric Gastroenterology and Nutrition 2004;39(Suppl 1):S33.
123. Campoy C, Escolano-Margarit MV, Ramos R, Parrilla-Roure M, Csabi G, Beyer J, et al. Effects of prenatal fish-oil and 5-methyltetrahydrofolate supplementation on cognitive development of children at 6.5 y of age. American Journal of Clinical Nutrition 2011;94(6 Suppl):1880S-8S.
124. Campoy C, Marchal G, Decsi T, Cruz M, Szabo E, Demmelmair H, et al. Spanish pregnant women's plasma phospholipids LC-PUFAs concentrations and its influence on their newborns. Journal of Pediatric Gastroenterology and Nutrition 2004;39(Suppl 1):S11.
125. Decsi T, Campoy C, Koletzko B. Effect of n-3 polyunsaturated fatty acid supplementation in pregnancy: the nuheal trial. Advances in Experimental Medicine and Biology 2005;569:109-13.
126. Demmelmair H, Klingler M, Campoy C, Decsi T, Koletzko B. Low eicosapentaenoic acid concentrations in fish oil supplements do not influence the arachidonic acid contents in placental lipids. Journal of Pediatric Gastroenterology and Nutrition 2004;39(Suppl 1):S11.
127. Demmelmair H, Klingler M, Campoy C, Diaz J, Decsi T, Veszpremi B, et al. The influence of habitual diet and increased docosahexaenoic acid intake during pregnancy on the fatty acid composition of individual placental lipids [abstract]. Journal of Pediatric Gastroenterology and Nutrition 2005;40(5):622-3.
128. Dolz V, Campoy C, Molloy A, Scott J, Marchal G, Decsi T, et al. Homocysteine, folate & methylenetetrahydrofolate reductase (MTHFR) 677-T poly-morphism in Spanish pregnant woman and in their offspring [abstract]. Journal of Pediatric Gastroenterology and Nutrition 2005;40(5):623-4.
129. Escolano-Margarit MV, Campoy C, Ramirez-Tortosa MC, Demmelmair H, Miranda MT, Gil A, et al. Effects of fish oil supplementation on the fatty acid profile in erythrocyte membrane and plasma phospholipids of pregnant women and their offspring: a randomised controlled trial. British Journal of Nutrition 2013;109(9):1614-56.
130. Escolano-Margarit MV, Ramos R, Beyer J, Csabi G, Parrilla-Roure M, Cruz F, et al. Prenatal DHA status and neurological outcome in children at age 5.5 years are positively associated. Journal of Nutrition 2011;141(6):1216-23.
131. Klingler M, Blaschitz A, Campoy C, Cano A, Molloy AM, Scott JM, et al. The effect of docosahexaenoic acid and folic acid supplementation on placental apoptosis and proliferation. British Journal of Nutrition 2006;96(1):182-90.
132. Krauss-Etschmann S, Hartl D, Heinrich J, Thaqi A, Prell C, Campoy C, et al. Association between levels of toll-like receptors 2 and 4 and CD14 mRNA and allergy in pregnant women and their offspring. Clinical Immunology 2006;118(2-3):292-9.
133. Krauss-Etschmann S, Hartl D, Rzehak P, Heinrich J, Shadid R, Del Carmen Ramirez-Tortosa M, et al. Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-beta levels after fish oil supplementation of pregnant women. Journal of Allergy and Clinical Immunology 2008;121(2):464-70.
134. Krauss-Etschmann S, Shadid R, Campoy C, Hoster E, Demmelmair H, Jimenez M, et al. Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial. American Journal of Clinical Nutrition 2007;85(5):1392-400.
135. Martin-Alvarez E, Guerrero-Montenegro B, Romero-Paniagua MT, Lara-Villoslada F, Hurtado-Suazo JA. Maternal docosahexaenoic acid supplementation during pregnancy and lactation can modulate oxidative stress in the term newborn. Journal of Maternal-Fetal and Neonatal Medicine 2012;25(S2):40.
136. Pena-Quintana L, Pena M, Rodriguez-Santana Y, Hurtado JA, Ochoa J, Sanjurjo P, et al. Consumption of a dairy product enriched with fish oil during pregnancy maintains the dha status of the mother and increase dha concentration in cord blood. Journal of Pediatric Gastroenterology and Nutrition 2011;52(Suppl 1):E84.
137. Ribeiro P, Carvalho FD, Abreu Ade A, Sant'anna Mde T, Lima RJ, Carvalho Pde O. Effect of fish oil supplementation in pregnancy on the fatty acid composition of erythrocyte phospholipids and breast milk lipids. International Journal of Food Sciences and Nutrition 2012;63(1):36-40.
138. Bisgaard H. Fish oil supplementation during pregnancy for prevention of asthma, eczema and allergies in childhood: interventional trial in the cCOPSAC2010 (Copenhagen studies on asthma in childhood) birth cohort. http://clinicaltrials.gov/ct2/show/NCT00798226 (accessed 15 September 2012).
139. Duchen K. Combined dietary supplementation with lactobacillus reuteri and omega-3 PUFA during pregnancy and postnatally in relation to development of IgE-associated disease during infancy. http://clinicaltrials.gov/ct2/show/NCT01542970 (accessed 15 September 2012).
140. Laitinen K. Nutrition and pregnancy intervention study. ClinicalTrials.gov (http://clinicaltrials.gov/ct2/show/NCT01922791) (accessed 5 February 2014). NCT01922791 2013.
141. Liu Z, Yin H. The effect of polyunsaturated fatty acids (PUFA) on allergic/atopic dermatitis. http://clinicaltrials.gov/ct2/show/NCT01936194 (verified September 2013) 2014.
142. Arkwright PD, David TJ. Allergic disorders. In: McIntosh N, Helms PJ, Smyth RL, Logan S editor(s). Forfar and Arneil's Test Book of Paediatrics. 7th Edition. Churchill Livingstone, 2008:1519-39.
143. Asher I, Baena-Cagnani C, Boner A, Canonica GW, Chuchalin A, Custovic A, et al. World Allergy Organization guidelines for prevention of allergy and allergic asthma. International Archives of Allergy and Immunology 2004;135(1):83-92.
144. Asher MI, Montefort S, Björkstén B, Lai CKW, Strachan DP, Weiland SK, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhino-conjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multi country cross-sectional surveys. Lancet 2006;368(9537):733-43.
145. Barbee RA, Murphy S. The natural history of asthma. Journal of Allergy and Clinical Immunology 1998;102(4 Pt 2):S65-S72.
146. Bousquet, J. Heinzerling, L. Bachert, C. Papadopoulos, N. G. Bousquet, P. J. Burney, P. G, et al. Practical guide to skin prick tests in allergy to aeroallergens. Allergy 2012;67(1):18-24.
147. Calder PC, Miles EA. Fatty acids and atopic disease. Pediatrics Allergy and Immunology 2000;13:29-36.
148. Calder PC. Polyunsaturated fatty acids and cytokine profiles: a clue to the changing prevalence of atopy?. Clinical and Experimental Allergy 2003; Vol. 33, issue 4:412-5. [PUBMED: 12680853]
149. Calder PC. n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. American Journal of Clinical Nutrition 2006;83(6):1505s-19s.
150. Calder PC. Immunomodulation by omega-3 fatty acids. Prostaglandins Leukotrine and Essential Fatty Acids 2007;77(5-6):327-35.
151. Calder PC. Does early exposure to long chain polyunsaturated fatty acids provide immune benefits?. Journal of Pediatrics 2010;156(6):869-71.
152. Calder PC, Kremmyda LS, Vlachava M, Noakes PS, Miles EA. Is there a role for fatty acids in early life programming of the immune system?. Proceedings of the Nutrition Society 2010;69(3):373-80. [PUBMED: 20462467]
153. Calvani M, Alessandri C, Sopo SM, Panetta V, Pingitore G, Tripodi S, et al. Consumption of fish, butter and margarine during pregnancy and development of allergic sensitizations in the offspring: role of maternal atopy. Pediatric Allergy and Immunology 2006;17(2):94-102.
154. de Jong AB, Dikkeschei LD, Brand PL. Sensitization patterns to food and inhalant allergens in childhood: a comparison of non-sensitized, monosensitized, and polysensitized children. Pediatric Allergy Immunology 2011;22(2):166-71.
155. Denburg JA, Hatfield HM, Cyr MM, Hayes L, Holt PG, Sehmi R, et al. Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatric Research 2005;57(2):276-81.
156. Escamilla-Nunez MC, Barraza-Villarreal A, Hernandez-Cadena L, Navarro-Olivos E, Sly PD, Romieu I. Omega-3 fatty acid supplementation during pregnancy and respiratory symptoms in children. Chest 2014;146(2):373-82.
157. Furuhjelm C, Warstedt K, Fageras M, Falth-Magnusson K, Larsson J, Fredriksson M, et al. Allergic disease in infants up to 2 years of age in relation to plasma omega-3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatric Allergy and Immunology 2011;22(5):505-14.
158. Georas SN, Guo J, De Fanis U, Casolaro V. T-helper cell type-2 regulation in allergic disease. European Respiratory Journal 2005;26(6):1119-37.
159. Greisner WA, Settipane RJ, Settipane GA. Natural history of hay fever: a 23-year follow-up of college students. Allergy and Asthma Proceedings 1998;19(5):271-5.
160. Gunaratne AW. Effects of n-3 LCPUFA Supplementation for Pregnant and Lactating Women in Preventing Allergic Disease in Early Childhood [PhD thesis (submitted)]. University of Adelaide, 2014 July.
161. Gupta R, Sheikh A, Strachan DP, Anderson HR. Burden of allergic disease in the UK: secondary analyses of national databases. Clinical and Experimental Allergy 2004;34(4):520-6.
162. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
163. Hodge L, Salome CM, Peat JK, Haby MM, Xuan W, Woolcock AJ. Consumption of oily fish and childhood asthma risk. Medical Journal of Australia 1996;164(3):137-40.
164. Imhoff-Kunsch B, Stein AD, Martorell R, Parra-Cabrera S, Romieu I, Ramakrishnan U. Prenatal docosahexaenoic acid supplementation and infant morbidity: randomized controlled trial. Pediatrics 2011;128(3):e505-12.
165. Johansson SGO, O'B Hourihane J, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813-24.
166. Johansson SGO, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. Journal of Allergy and Clinical Immunology 2004;113(5):832-36.
167. Kemp AS. Atopic eczema: its social and financial costs. Journal of Paediatrics and Child Health 1999;35(3):229-31.
168. Klemens CM, Berman DR, Mozurkewich EL. The effect of perinatal omega-3 fatty acid supplementation on inflammatory markers and allergic diseases: a systematic review. BJOG: an international journal of obstetrics and gynaecology 2011;118(8):916-25.
169. Krauss-Etschmann S, Hartl D, Rzehak P, Heinrich J, Shadid R, Ramírez-Tortosa MDC, et al. Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-beta levels after fish oil supplementation of pregnant women. Journal of Allergy and Clinical Immunology 2008;121(2):464-70.
170. Kremmyda LS, Vlachava M, Noakes PS, Diaper ND, Miles EA, Calder PC. Atopy risk in infants and children in relation to early exposure to fish, oily fish, or long-chain omega-3 fatty acids: a systematic review. Clinical Review Allergy Immunology 2011; Vol. 41, issue 1:36-66.
171. Lauritzen L, Jorgensen MH, Mikkelsen TB, Skovgaard M, Straarup EM, Olsen SF, et al. Maternal fish oil supplementation in lactation: effect on visual acuity and n-3 fatty acid content of infant erythrocytes. Lipids 2004;34(3):195-206.
172. Lee HS, Barraza-Villarreal A, Hernandez-Vargas H, Sly PD, Biessy C, Ramakrishnan U, et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with ω-3 PUFA during pregnancy in an intervention study. American Journal of Clinical Nutrition 2013;98:480-7.
173. Makrides M, Duley L, Olsen SF. Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD003402.pub2]
174. Manley BJ, Makrides M, Collins CT, McPhee AJ, Gibson RA, Ryan P, et al. DINO Steering Committee. High-dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics 2011;128(1):e71-7.
175. Meyer BJ, Mann NJ, Lewis JL, Milligan GC, Sinclair AJ, Howe PR. Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids. Lipids 2003;38(4):391-8.
176. Mihrshahi S, Peat JK, Webb K, Oddy W, Marks GB, Mellis CM. Effect of omega-3 fatty acid concentrations in plasma on symptoms of asthma at 18 months of age. Pediatric Allergy and Immunology 2004;15(6):517-22.
177. Miles EA, Noakes PS, Kremmyda LS, Vlachava M, Diaper ND, Rosenlund G, et al. The Salmon in Pregnancy Study: study design, subject characteristics, maternal fish and marine n-3 fatty acid intake, and marine n-3 fatty acid status in maternal and umbilical cord blood. American Journal of Clinical Nutrition 2011;94(6 Suppl):1986S-92S.
178. Oddy WH, de Klerk NH, Kendall GE, Mihrshahi S, Peat JK. Ratio of omega-6 to omega-3 fatty acids and childhood asthma. Journal of Asthma 2004;41(3):319-26.
179. Oken E, Kleinman KP, Berland WE, Simon SR, Rich-Edwards JW, Gillman MW, et al. Decline in fish consumption among pregnant women after a national mercury advisory. Obstetrics and Gynecology 2003;102(2):346-51.
180. Olsen SF, Osterdal ML, Salvig JD, Mortensen LM, Rytter D, Secher NJ, et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry-based follow-up from a randomized controlled trial. American Journal of Clinical Nutrition 2008;88(1):167-75.
181. Oranje AP. Development of childhood eczema and its classification. Pediatric Allergy and Immunology 1995;6 Suppl 7:31-5.
182. Palmer DJ, Sullivan T, Gold MS, Prescott SL, Heddle R, Gibson RA, et al. Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ 2012;344(e184):1-11.
183. Palmer DJ, Sullivan T, Gold MS, Prescott SL, Heddle R, Gibson RA, et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies. Allergy 2013;68(11):1370-6.
184. Pawanker RCG, Holgate ST, Lockey RF, editors. WAO White Book On Allergy. World Allergy Organization (WAO), 2011.
185. Prescott SL, Calder PC. N-3 polyunsaturated fatty acids and allergic disease. Current Opinion in Clinical Nutrition and Metabolic Care 2004;7:123-9.
186. Prescott SL, Dunstan JA. Prenatal fatty acid status and immune development: the pathways and the evidence. Lipids 2007;42(9):801-10.
187. Prescott SL, Barden AE, Mori TA, Dunstan JA. Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord-blood-derived neutrophils. Clinical Science (Lond) 2007;113(10):409-16.
188. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
189. Romero VC, Somers EC, Stolberg V, Clinton C, Chensue S, Djuric Z, et al. Developmental programming for allergy: a secondary analysis of the Mothers, Omega-3, and Mental Health Study. American Journal of Obstetrics and Gynecology 2013;208(4):316.e.1-6.
190. Romieu I, Torrent M, Garcia-Esteban R, Ferrer C, Ribas-Fitó N, Antó JM, et al. Maternal fish intake during pregnancy and atopy and asthma in infancy. Clinical and Experimental Allergy 2007;37(4):518-25.
191. Saarinen UM, Kajosaari M. Breastfeeding as prophylaxis against atopic disease: prospective follow-up study until 17 years old. Lancet 1995;346(8982):1065-9.
192. Sausenthaler S, Koletzko S, Schaaf B, Lehmann I, Borte M, Herbarth O, et al. Maternal diet during pregnancy in relation to eczema and allergic sensitization in the offspring at 2 y of age. American Journal of Clinical Nutrition 2007;85(2):530-7.
193. Sears MR, Holdaway MD, Flannery EM, Herbison GP, Silva PA. Parental and neonatal risk factors for atopy, airway hyper-responsiveness, and asthma. Archives of Disease in Childhood 1996;75(5):392-8.
194. Sicherer SH, Wood RA. Allergy testing in childhood: using allergen-specific IgE tests. Pediatrics 2012;129(1):193-7.
195. Simmonds L. Behavioural and Allergic Disease Assessment at Pre-School Age: A Follow-up Study of Preterm Infants Fed Docosahexaenoic Acid Supplementation in the Neonatal Period [dissertation]. University of Adelaide, 2007 Nov.
196. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. American Journal of Clinical Nutrition 1991;54:438-63.
197. Snijdewint FG, Kalinski P, Wierenga EA, Bos JD, Kapsenberg ML. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. Journal of Immunology 1993;150(12):5321-9.
198. Spergel JM, Paller AS. Atopic dermatitis and the atopic march. Journal of Allergy and Clinical Immunology 2003;112(6 Suppl):S118-27.
199. Spergel JM. From atopic dermatitis to asthma: the atopic march. Annals of Allergy Asthma and Immunology 2010;105(2):99-106.
200. Strong K, Mathers C, Leeder S, Beaglehole R. Preventing chronic diseases: how many lives can we save?. Lancet 2005;366(9496):1578-82.
201. Wilczynski JR. Th1/Th2 cytokines balance-yin and yang of reproductive immunology. European Journal of Obstetrics & Gynecology and Reproductive Biology 2005;122(2):136-43.
202. Willers SM, Devereux G, Craig LC, McNeill G, Wijga AH, Abou El-Magd W, et al. Maternal food consumption during pregnancy and asthma, respiratory and atopic symptoms in 5-year-old children. Thorax 2007;62(9):773-9.
203. Gunaratne AW, Makrides M, Collins CT. Maternal prenatal and/or postnatal n-3 fish oil supplementation for preventing allergies in early childhood. Cochrane Database of Systematic Reviews 2012, Issue 9. [DOI: 10.1002/14651858.CD010085]